SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Banisor, I.
Right arrow Articles by Kalman, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Banisor, I.
Right arrow Articles by Kalman, B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Bcl-2 and its homologues in the brain of patients with multiple sclerosis

Ileana Banisor

Department of Neurology, SLRHC, Hospital of Columbia University, New York, USA

Bernadette Kalman

Department of Neurology, SLRHC, Hospital of Columbia University, New York, USA, BKalman{at}chpnet.org

We measured the mRNA expression levels of molecules involved in scavenging free radicals and in apoptosis within normal appearing white and gray matter (NAWM and NAGM, respectively) and chronic active plaque containing frontal lobe specimens of patients with multiple sclerosis (MS). While no regional differences were detected in the mRNA levels of free radical scavengers, Bcl-XL was higher in plaques than in NAWMs, and both Bak and Bcl-2 were found to be increased in correlation with an immune marker (b2-microglobulin - b2Mg) in NAWM and plaque compared with corresponding cortical regions. We did not measure a similar white -gray matter difference in the expression of the latter genes in brains of normal or A lzheimer disease controls. This finding indicates that both pro- and anti- apoptotic mechanisms are activated, not only within but also outside of plaques.

Key Words: apoptosis • molecular pathology • multiple sclerosis

Multiple Sclerosis, Vol. 10, No. 2, 176-181 (2004)
DOI: 10.1191/1352458504ms995oa


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
IOVSHome page
X. Qi, L. Sun, A. S. Lewin, W. W. Hauswirth, and J. Guy
Long-term Suppression of Neurodegeneration in Chronic Experimental Optic Neuritis: Antioxidant Gene Therapy
Invest. Ophthalmol. Vis. Sci., December 1, 2007; 48(12): 5360 - 5370.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
X. Qi, A. S. Lewin, L. Sun, W. W. Hauswirth, and J. Guy
Suppression of Mitochondrial Oxidative Stress Provides Long-term Neuroprotection in Experimental Optic Neuritis
Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 681 - 691.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
L Lopatinskaya, J Zwemmer, B Uitdehaag, K Lucas, C Polman, and L Nagelkerken
Mediators of apoptosis Fas and FasL predict disability progression in multiple sclerosis over a period of 10 years
Multiple Sclerosis, November 1, 2006; 12(6): 704 - 709.
[Abstract] [PDF]



Advertisement